Literature DB >> 27456965

Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.

F X Aymerich1,2, C Auger3, P Alcaide-Leon3, D Pareto3, E Huerga3, J F Corral3, R Mitjana3, J Sastre-Garriga4, X Montalban4, A Rovira3.   

Abstract

OBJECTIVES: To compare the sensitivity of enhancing multiple sclerosis (MS) lesions in gadolinium-enhanced 2D T1-weighted gradient-echo (GRE) and spin-echo (SE) sequences, and to assess the influence of visual conspicuity and laterality on detection of these lesions.
METHODS: One hundred MS patients underwent 3.0T brain MRI including gadolinium-enhanced 2D T1-weighted GRE and SE sequences. The two sets of contrast-enhanced scans were evaluated in random fashion by three experienced readers. Lesion conspicuity was assessed by the image contrast ratio (CR) and contrast-to-noise ratio (CNR). The intracranial region was divided into four quadrants and the impact of lesion location on detection was assessed in each slice.
RESULTS: Six hundred and seven gadolinium-enhancing MS lesions were identified. GRE images were more sensitive for lesion detection (0.828) than SE images (0.767). Lesions showed a higher CR in SE than in GRE images, whereas the CNR was higher in GRE than SE. Most misclassifications occurred in the right posterior quadrant.
CONCLUSIONS: The gadolinium-enhanced 2D T1-weighted GRE sequence at 3.0T MRI enables detection of enhancing MS lesions with higher sensitivity and better lesion conspicuity than 2D T1-weighted SE. Hence, we propose the use of gadolinium-enhanced GRE sequences rather than SE sequences for routine scanning of MS patients at 3.0T. KEY POINTS: • 2D SE and GRE sequences are useful for detecting active MS lesions. • Which of these sequences is more sensitive at high field remains uncertain. • GRE sequence showed better sensitivity for detecting active MS lesions than SE. • We propose GRE sequence for detecting active MS lesions at 3.0T.

Entities:  

Keywords:  Brain; Contrast sensitivity; Lesion conspicuity; Magnetic resonance imaging; Multiple sclerosis

Mesh:

Substances:

Year:  2016        PMID: 27456965     DOI: 10.1007/s00330-016-4503-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

1.  A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.

Authors:  Elliot M Frohman; Gary Cutter; Gina Remington; Hongjiang Gao; Howard Rossman; Bianca Weinstock-Guttman; Jacqueline E Durfee; Amy Conger; Ellen Carl; Katherine Treadaway; Eric Lindzen; Amber Salter; Teresa C Frohman; Anjali Shah; Angela Bates; Jennifer L Cox; Michael G Dwyer; Olaf Stüve; Benjamin M Greenberg; Michael K Racke; Robert Zivadinov
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis?

Authors:  M P Wattjes; M Harzheim; C K Kuhl; J Gieseke; S Schmidt; L Klotz; T Klockgether; H H Schild; G G Lutterbey
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

3.  Lesion conspicuity, structured noise, and film reader error.

Authors:  H L Kundel; G Revesz
Journal:  AJR Am J Roentgenol       Date:  1976-06       Impact factor: 3.959

4.  Accuracy of postcontrast 3D turbo spin-echo MR sequence for the detection of enhanced inflammatory lesions in patients with multiple sclerosis.

Authors:  J Hodel; O Outteryck; E Ryo; A-L Bocher; O Lambert; D Chéchin; H Zéphir; A Lacour; J-P Pruvo; P Vermersch; X Leclerc
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-07       Impact factor: 3.825

Review 5.  MR imaging in multiple sclerosis: review and recommendations for current practice.

Authors:  K-O Lövblad; N Anzalone; A Dörfler; M Essig; B Hurwitz; L Kappos; S-K Lee; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

6.  Visual conspicuity: a new simple standard, its reliability, validity and applicability.

Authors:  A H Wertheim
Journal:  Ergonomics       Date:  2010-03       Impact factor: 2.778

7.  Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes.

Authors:  M Gómez-Moreno; M Díaz-Sánchez; A Ramos-González
Journal:  Mult Scler       Date:  2011-08-24       Impact factor: 6.312

Review 8.  Enhanced magnetic resonance imaging in multiple sclerosis.

Authors:  M Filippi
Journal:  Mult Scler       Date:  2000-10       Impact factor: 6.312

9.  Theoretical analysis of gadopentetate dimeglumine enhancement in T1-weighted imaging of the brain: comparison of two-dimensional spin-echo and three-dimensional gradient-echo sequences.

Authors:  J P Mugler; J R Brookeman
Journal:  J Magn Reson Imaging       Date:  1993 Sep-Oct       Impact factor: 4.813

10.  Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla.

Authors:  Nancy L Sicotte; Rhonda R Voskuhl; Seth Bouvier; Rochelle Klutch; Mark S Cohen; John C Mazziotta
Journal:  Invest Radiol       Date:  2003-07       Impact factor: 6.016

View more
  1 in total

1.  T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis.

Authors:  Christian Thaler; Tanja Schneider; Jan Sedlacik; Daniel Kutzner; Jan-Patrick Stellmann; Christoph Heesen; Jens Fiehler; Susanne Siemonsen
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.